Emergency Vaccination Reduces Deaths by 60 Percent Worldwide
Vaccination efforts have significantly decreased deaths from outbreaks and prevented infections, generating billions in economic benefits.
A comprehensive study released this week reveals that emergency vaccination during outbreaks of diseases such as cholera, Ebola, measles, meningitis, and yellow fever has reduced deaths by nearly 60 percent over the past quarter-century.
In addition to saving lives, similar numbers of infections have been prevented, and billions of euros in economic benefit have been generated.
This groundbreaking research was a collaboration between Gavi, the vaccine alliance, and researchers at Burnet Institute in Australia, providing the first-ever quantitative assessment of emergency immunization efforts' impact on public health and global health security.
The study, published in the British Medical Journal Global Health, examined 210 outbreaks across 49 lower-income countries between 2000 and 2023.
It found that vaccine roll-outs dramatically reduced both infections and deaths, with a particularly striking effect on yellow fever and Ebola, decreasing deaths by 99 percent and 76 percent respectively during outbreaks.
The economic benefits from averting deaths and years of life lost to disability were estimated at nearly $32 billion, though the study noted this figure likely underestimates overall savings.
This analysis comes amid rising concerns over the resurgence of vaccine-preventable diseases due to misinformation and cuts in international aid.
Gavi, a key player in global vaccination efforts, is currently seeking new funding sources as it faces challenges from global aid reductions and the recent U.S. decision to discontinue its financial support.
In addition to saving lives, similar numbers of infections have been prevented, and billions of euros in economic benefit have been generated.
This groundbreaking research was a collaboration between Gavi, the vaccine alliance, and researchers at Burnet Institute in Australia, providing the first-ever quantitative assessment of emergency immunization efforts' impact on public health and global health security.
The study, published in the British Medical Journal Global Health, examined 210 outbreaks across 49 lower-income countries between 2000 and 2023.
It found that vaccine roll-outs dramatically reduced both infections and deaths, with a particularly striking effect on yellow fever and Ebola, decreasing deaths by 99 percent and 76 percent respectively during outbreaks.
The economic benefits from averting deaths and years of life lost to disability were estimated at nearly $32 billion, though the study noted this figure likely underestimates overall savings.
This analysis comes amid rising concerns over the resurgence of vaccine-preventable diseases due to misinformation and cuts in international aid.
Gavi, a key player in global vaccination efforts, is currently seeking new funding sources as it faces challenges from global aid reductions and the recent U.S. decision to discontinue its financial support.
